Orthopedic Bone Cement Market Report 2024

This Orthopedic Bone Cement market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The orthopedic bone cement market size has grown strongly in recent years. It will grow from $0.93 billion in 2023 to $0.98 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The historical growth can be attributed to an aging population, a rise in osteoporosis cases, an increase in joint disorders, higher healthcare expenditure, growing awareness, and improved healthcare access.

The orthopedic bone cement market size is expected to see strong growth in the next few years. It will grow to $1.25 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The anticipated growth during the forecast period can be attributed to a rising demand for minimally invasive procedures, an increase in orthopedic disorders, the expansion of orthopedic surgery centers, growing investment in healthcare infrastructure, and a rise in high-impact sports and activities. Key trends for this period include technological advancements, innovations in bone cement technology, development of biodegradable and bioactive cements, adoption of antibiotic-loaded cements, and the creation of smart bone cements.

The increasing incidence of accidents and injuries is expected to propel the growth of the orthopedic bone cement market going forward. The rising incidence of accidents and injuries is driven by factors such as higher traffic volumes, more frequent high-risk activities, distracted driving, and inadequate safety measures. Orthopedic bone cement is used to treat injuries to secure implants and facilitate the repair of fractures and damaged joints, ensuring stability and promoting healing. For instance, in April 2024, according to the report published by the National Highway Traffic Safety Administration (NHTSA), a U.S. government agency responsible for ensuring road safety, around 2.38 million individuals were injured in motor vehicle traffic crashes in 2022, compared to 2.28 million in 2021. Therefore, the increasing incidence of accidents and injuries will drive the growth of the orthopedic bone cement market.

Major companies operating in the orthopedic bone cement market are focusing on developing innovative products, such as antibiotic-loaded spacers, to enhance infection control during joint replacement surgeries and improve patient outcomes. Antibiotic-loaded spacers are temporary implants used in orthopedic surgery, particularly in treating infected joint prostheses, such as those in the hip or knee. These spacers are made from bone cement (typically polymethylmethacrylate, or PMMA) mixed with antibiotics. For instance, in November 2023, Biocomposites Ltd., a UK-based medical device company, launched the SYNICEM hip, knee, and shoulder performed spacers, which have demonstrated success in patients undergoing joint surgery. These antibiotic-loaded, preformed spacers address the limitations of traditional intra-operative molded and handmade spacers. They support surgeons during hip, knee, and shoulder revisions by maintaining joint space and effectively treating infections. It is designed with precision for consistent performance and structural integrity. SYNICEM spacers deliver a high local concentration of gentamicin and offer flexible, time-saving solutions for surgeons during procedures. It specializes in bone cement and polymer-based products, utilizing proprietary core polymer production and in-house formulation techniques.

In January 2024, Enovis, a U.S.-based medical technology company specializing in orthopedic products and services, announced its acquisition of LimaCorporate for an undisclosed sum. This acquisition strengthens Enovis's orthopedic portfolio, especially in joint reconstruction, by incorporating innovative implant technologies. LimaCorporate, based in Italy, is known for its expertise in bone cement.

Major companies operating in the orthopedic bone cement market are Johnson & Johnson Services Inc., 3M Company, Medtronic plc, Stryker Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Cook Medical LLC, Enovis Corporation, Globus Medical Inc., Wright Medical Group N.V., Medacta International SA, Orthofix Medical Inc., ATEC Spine Inc., Exactech Inc., Spine Wave Inc., Tecres S.p.A., Somatex Medical Technologies GmbH, Heraeus Medical GmbH, DJO Global Inc., TEKNIMED SAS, G-21 SRL, Kyeron Medical Innovations Inc., Graftys SA.

North America was the largest region in the orthopedic bone cement market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthopedic bone cement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the orthopedic bone cement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Orthopedic bone cement is a medical-grade adhesive used in orthopedic surgeries to stabilize and fix implants within the body, such as artificial joints and bone fragments. It is commonly applied in procedures such as hip and knee replacements to enhance the bond between the implant and the bone, aiding in effective healing and stability.

The main types of orthopedic bone cement are low-viscosity, medium-viscosity, and high-viscosity cements. Low-viscosity cements have a thinner, more fluid consistency, allowing them to flow easily into small bone cavities and provide a uniform coating around the implant during surgery. The material types include polymethyl methacrylate (PMMA), ceramic, acrylic, and others. End users of orthopedic bone cement include hospitals, orthopedic clinics and centers, and other healthcare facilities.

The orthopedic bone cement market research report is one of a series of new reports that provides orthopedic bone cement market statistics, including orthopedic bone cement industry global market size, regional shares, competitors with an orthopedic bone cement market share, detailed orthopedic bone cement market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic bone cement industry. This orthopedic bone cement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The orthopedic bone cement market consists of sales of antibiotic-loaded bone cement, calcium phosphate cement, biodegradable bone cement, and bone void fillers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.